Praluzatamab is a monoclonal antibody targeting an activated white blood cell adhesion molecule (ALCAM/CD116). It is a naked antibody used to synthesize antibody active molecule conjugates (Praluzatamab ravtansine) and can be employed to study breast cancer.
Purity:
100.00%
CAS Number:
[2145109-70-0]
Target:
Immunology/Inflammation related|||ADC Antibody
* VAT and and shipping costs not included. Errors and price changes excepted